| Literature DB >> 33060108 |
Zuguang Gu1,2, Charles D Imbusch3, Martin R Sprick4,5, Andreas Trumpp6,5,7, Elisa Espinet6,5,7, Nathalia A Giese8, Magdalena Büscher4,5, Mariam Safavi4,5, Silke Weisenburger4,5, Corinna Klein4, Vanessa Vogel4, Mattia Falcone4,5, Jacob Insua-Rodríguez4,5, Manuel Reitberger4,5, Vera Thiel4,5, Steffi O Kossi4, Alexander Muckenhuber9, Karnjit Sarai10, Alex Y L Lee10, Elyne Backx11, Soheila Zarei10, Matthias M Gaida12,13, Manuel Rodríguez-Paredes14, Elisa Donato4,5, Hsi-Yu Yen9, Roland Eils2,15,16, Matthias Schlesner1, Nicole Pfarr9, Thilo Hackert8, Christoph Plass17, Benedikt Brors7,3, Katja Steiger7,9, Dieter Weichenhan2, H Efsun Arda18, Ilse Rooman11, Janel L Kopp10, Oliver Strobel8,19, Wilko Weichert7,9.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive desmoplasia, which challenges the molecular analyses of bulk tumor samples. Here we FACS-purified epithelial cells from human PDAC and normal pancreas and derived their genome-wide transcriptome and DNA methylome landscapes. Clustering based on DNA methylation revealed two distinct PDAC groups displaying different methylation patterns at regions encoding repeat elements. Methylationlow tumors are characterized by higher expression of endogenous retroviral transcripts and double-stranded RNA sensors, which lead to a cell-intrinsic activation of an interferon signature (IFNsign). This results in a protumorigenic microenvironment and poor patient outcome. Methylationlow/IFNsignhigh and Methylationhigh/IFNsignlow PDAC cells preserve lineage traits, respective of normal ductal or acinar pancreatic cells. Moreover, ductal-derived Kras G12D/Trp53 -/- mouse PDACs show higher expression of IFNsign compared with acinar-derived counterparts. Collectively, our data point to two different origins and etiologies of human PDACs, with the aggressive Methylationlow/IFNsignhigh subtype potentially targetable by agents blocking intrinsic IFN signaling. SIGNIFICANCE: The mutational landscapes of PDAC alone cannot explain the observed interpatient heterogeneity. We identified two PDAC subtypes characterized by differential DNA methylation, preserving traits from normal ductal/acinar cells associated with IFN signaling. Our work suggests that epigenetic traits and the cell of origin contribute to PDAC heterogeneity.This article is highlighted in the In This Issue feature, p. 521. ©2020 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33060108 PMCID: PMC9216338 DOI: 10.1158/2159-8290.CD-20-1202
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 38.272